The complementary role of drug, ablation and device in the electrical therapy of atrial fibrillation

European Heart Journal, Supplement

Volumn 3, Issue P, 2001, Pages

  Capucci, Alessandro ^a   Villani, G Q ^a   Marrazzo, N ^a   Piepoli, M ^a  

^a Ospedale Civile   (Italy)

Author keywords

Antiarrhythmic drugs; Atrial cardioversion; Atrial fibrillation; Dual chamber pacing; Implantable cardioverter defibrillator; Radiofrequency ablation

Indexed keywords

ANTIARRHYTHMIC AGENT;

ARTICLE; CARDIOVERSION; CATHETER ABLATION; DEFIBRILLATOR; DRUG EFFICACY; ELECTRIC CONDUCTIVITY; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HUMAN; HYBRID; IMPLANT; PRIORITY JOURNAL; SINUS RHYTHM; TREATMENT PLANNING;

EID: 0035177146     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1520-765X(01)90072-0     Document Type: Article

References (40)

1. Prevalence of AF in elderly subjects (The Cardiovascular Health Study)
2. Management of patients with AF. A statement for healthcare professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association
3. Selecting an antiarrhythmic agent for AF should be a patient-specific, data-driven decision
4. Prevention of symptomatic recurrences of paroxismal AF in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind crossover study of flecainide and placebo with transtelephonic monitoring
5. AF begets AF. A study in awake chronically instrumented goats
6. Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias. A randomized, placebo-controlled, crossover trial in patients tolerating oral therapy
7. Efficacy and safety of quinidine therapy for manteinance of sinus rhythm after cardioversion: A meta-analysis of randomized control trials
8. Antiarrhythmic drug therapy and cardiac mortality in AF
9. The Surgical treatment of AF. II. Intraoperative electrphysiologic mapping and description of the electrophysiologic basis of atrial flutter and AF
10. A focal source of AF treated by discrete radiofrequency ablation
11. Right and left strial radiofrequency catheter therapy of paroxysmal AF
12. Right atrial radiofrequency catheter ablation of paroxysmal AF
13. Long-term pacing in sinus node disease: Effect of stimulation mode on cardiovascular mortality and morbidity
14. Chronic AF and stroke in paced patients with sick sinus syndrome. Relevance of clinical characteristics and pacing modalities
15. Specific considerations with the automatic implantable atrial defibrillator
16. Spontaneous episodes of atrial fibrillation after implantation of the Metrix Atrioverter: Observations on treated and nontreated episodes
17. Combined approach of pharmacological and non-pharmacological treatment of atrial fibrillation
18. Can linear lesion facilitate pace termination of atrial arrhythmia in an AF substrate?
19. Initial experience with a combination of atrial pacing and atrial ablation therapy for management of AF
20. Benefits of a hybrid therapy for AF
21. Catheter ablation of atrial flutter due to amiodarone therapy for paroxysmal AF
22. Response to flecainide infusion predicts long-term success of inferior vena cava-tricuspid annulus ablation in patients with AF
23. Potential role of 'hybrid therapy' for AF
24. Long-term outcome of patients with drug- refractory atrial flutter and fibrillation after single-dual-site right atrial pacing for arrhythmia prevention
25. Prevention of recurrent AF with chronic dual-site right atrial pacing
26. Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment
27. Favorable effects of flecainide in transvenous internal cardioversion of atrial fibrillation
28. Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation
29. Efficacy of antitachy pacing therapies and low energy cardioversion in terminating spontaneous atrial tachyarrhythmias in patients with dual impiantable defibrillator
30. Capture of atrial fibrillation reduces the intraatrial defibrillation threshold
31. Influence of atrioventricular junction ablation in patients with chronic atrial fibrillation and flutter on quality of life and cardiac performance
32. Prospective study of left ventricular function after radiofrequency ablation of atrioventricular junction in patients with atrial fibrillation
33. Quality of life and outcomes after radiofrequency His-bundle catheter ablation and permanent pacemaker implantation: Impact of treatment in paroxysmal and established atrial fibrillation
34. AV node ablation and pacemaker implantation after withdrawal of effective rate-control medications for chronic atrial fibrillation: Effect on quality of life and exercise performance
35. Symptomatic improvement after AV nodal ablation and pacemaker implantation for refractory atrial fibrillation and atrial flutter
36. Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patient with heart failure and chronic atrial fibrillation: A randomized controlled study
37. The ABlate and Pace Trial: A prospective stucy of catheter ablation of the AV conduction system and permanent pacemaker implantation for the treatment of atrial fibrillation
38. The North American experience with the Ablate and Pace Trial (APT) for medically refractory atrial fibrillation
39. Ablate and pace: Palliating the symptoms?
40. Report of a study group on ablate and pace therapy for paroxysmal atrial fibrillation